Resonance Health LtdASX: RHT

TrialsWest Expands with New Clinical Trial Site

· Issued by Resonance Health Ltd

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Resonance Health Ltd announces the expansion of TrialsWest with a new clinical trial site in Mandurah, Western Australia, expected to open soon. This new site will significantly increase participant capacity and support ongoing major pharmaceutical trials managed by Resonance Health. The expansion aligns with the company's strategy to grow its clinical trial operations in densely populated areas with low establishment costs. CEO Andrew Harrison expressed optimism about the growth opportunities this new site presents for the TrialsWest business.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Resonance Health Ltd on 6ix

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases